Integra LifeSciences Holdings Corporation has grown revenue 2.2% a year over three years and 1.8% a year over five. Revenue growth, 3-year annual rate: +2.2% (Medical Devices median +12%). Revenue growth, 5-year rate: +1.8%, growth has picked up over the last three years. Years of annual history on file: 18, FY2008 to FY2025, as filed.

IARTIntegra LifeSciences Holdings Corporation

Healthcare

$13.44-4.9% 1Y

$13.44

$8.9052 weeks$19.87

Is it growing?

Mixed

Neither accelerating nor breaking down: nothing decisive, though operating margin widening (+34.3 points).

1 good, 1 neutral, 1 without data

Revenue trend+2% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +2% a year.

Margin direction+34.3 points operating

Trailing-twelve-month operating margin, 3.9% now against -30.4% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbehind 68% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is IART growing?

Integra LifeSciences Holdings Corporation has grown revenue 2.2% a year over three years and 1.8% a year over five.

+2.2%

Revenue growth, 3-year annual rate · Medical Devices median +12% · growing slowly · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +1.8%
Revenue growth, 5-year rate · +2.2% over three · growth has picked up over the last three years
Years of annual history on file: 18
Years of annual history on file · FY2008 to FY2025, as filed

Details›